US CMS Sets Out Competitive Bidding Rental Model for CGMs; Abbott, Dexcom Could Face Impact

Analysts Expect Proposal Could Take Multiple Years To Execute

 
• By Shubham Singh
  
This is expected to reshape margins and business models for leading diabetes technology companies including Abbott, Dexcom, Tandem Diabetes Care, Beta Bionics, Medtronic, and Insulet. (Shutterstock)

More from Diabetic Care

More from Device Area